NCT04296591

Brief Summary

Objective: The aim of this study was to investigate the efficacy of fetal right heart doppler findings in determination of pulmonary maturity. Materials and Methods: Pregnant women refered to the Department of Obstetrics and Gynecology at Karadeniz Technical University were included in the study. Pregnant women with pregestational or gestational diabetes mellitus, morbid obesity, thyroid dysfunction and fetal abnormality aneuploidy were not included in the study. The study was planned on women with late preterm and term pregnancy. Late preterm cases between 34-37 weeks were included in study group and term cases over 37 weeks were in control group. The doppler findings of main pulmonary artery and right pulmonary artery, mitral valve e/a wave ratio and lamellar body count were determined as the main outcomes. During caesarean section, 5cc amniotic fluid was taken to measure lamellar bodies count. Perinatal results of patients were recorded. p\<0.05 was considered as statistical significance.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
Last Updated

March 5, 2020

Status Verified

March 1, 2020

Enrollment Period

2.4 years

First QC Date

February 25, 2020

Last Update Submit

March 4, 2020

Conditions

Keywords

LAMELLAR BODYpulmonary maturationdoppler ultrasonographyfetal pulmonary artery

Outcome Measures

Primary Outcomes (2)

  • lamellar body count

    lamellar body count was higher in the control group

    immediately after the procedure(1year)

  • Doppler data of main pulmonary artery and right pulmonary artery, mitral valve e/a wave ratio

    this data was measured before cesarian section.significant/ nonsignificant differences were detected between groups

    immediately after the procedure (1year)

Study Arms (2)

study group

The study group consisted of late preterm cases(34-37 weeks of gestation) and

Diagnostic Test: fetal heart doppler findings

control group

the control group consisted of term cases (\<37 weeks of gestation).

Diagnostic Test: fetal heart doppler findings

Interventions

Doppler data of main pulmonary artery and right pulmonary artery, mitral valve e/a wave ratio and lamellar body count were determined as the main research parameters. In both groups, fetal thorax and heart circumference ratio, mitral e/a wave ratio, right pulmonary artery and main pulmonary doppler indexes (PI, RI, S / D, AT / ET) were evaluated before cesarean section.

Also known as: lamellar body count
control groupstudy group

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnancy woman
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

total of 70 pregnant women (n: 70), 25 in the study group and 45 in the control group

You may qualify if:

  • preterm and term pregnancy
  • caesarean cases

You may not qualify if:

  • pregestational diabetes mellitus
  • gestational diabetes mellitus
  • morbid obesity
  • thyroid dysfunction
  • fetal anomaly diagnosed an euploidy or anomaly.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature BirthObstetric Labor, Premature

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • ERHAN HUSEYIN COMERT

    Karadeniz Technical University

    PRINCIPAL INVESTIGATOR
  • TURHAN ARAN, PROF

    Karadeniz Technical University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research asistant

Study Record Dates

First Submitted

February 25, 2020

First Posted

March 5, 2020

Study Start

January 1, 2017

Primary Completion

June 1, 2019

Study Completion

August 1, 2019

Last Updated

March 5, 2020

Record last verified: 2020-03